Glycostem Therapeutics BV
Glycostem Therapeutics is a Netherlands based lifescience company which is active in the field of cellular immunotherapy, creating scientific and clinical breakthroughs in the expansion, differentiation and application of hematopoietic stem cells.
Glycostem Therapeutics has developed a new and innovative cell culture system for the ex-vivo generation of clinically relevant amounts of Natural Killer cells (NK-cells). These cells are the body’s natural defense against ‘unwanted’ cells like cancer cells. Boosting their numbers and function can contribute to the immunotherapy of several diseases, especially several types of cancer.
For more information: www.glycostem.com